DE3363647D1 - Process for recovering human ifn-beta from a transformed microorganism - Google Patents

Process for recovering human ifn-beta from a transformed microorganism

Info

Publication number
DE3363647D1
DE3363647D1 DE8383900886T DE3363647T DE3363647D1 DE 3363647 D1 DE3363647 D1 DE 3363647D1 DE 8383900886 T DE8383900886 T DE 8383900886T DE 3363647 T DE3363647 T DE 3363647T DE 3363647 D1 DE3363647 D1 DE 3363647D1
Authority
DE
Germany
Prior art keywords
beta
human ifn
transformed microorganism
recovering human
recovering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383900886T
Other languages
English (en)
Inventor
Michael W Konrad
Leo S Lin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Application granted granted Critical
Publication of DE3363647D1 publication Critical patent/DE3363647D1/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE8383900886T 1982-03-01 1983-02-10 Process for recovering human ifn-beta from a transformed microorganism Expired DE3363647D1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/353,360 US4450103A (en) 1982-03-01 1982-03-01 Process for recovering human IFN-β from a transformed microorganism
PCT/US1983/000177 WO1983003103A1 (en) 1982-03-01 1983-02-10 PROCESS FOR RECOVERING HUMAN IFN-'beta' FROM A TRANSFORMED MICROORGANISM

Publications (1)

Publication Number Publication Date
DE3363647D1 true DE3363647D1 (en) 1986-07-03

Family

ID=23388775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383900886T Expired DE3363647D1 (en) 1982-03-01 1983-02-10 Process for recovering human ifn-beta from a transformed microorganism

Country Status (8)

Country Link
US (1) US4450103A (de)
EP (1) EP0102989B1 (de)
JP (1) JPS59500597A (de)
AU (1) AU549721B2 (de)
CA (1) CA1187013A (de)
DE (1) DE3363647D1 (de)
IT (1) IT1164626B (de)
WO (1) WO1983003103A1 (de)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JPS60118196A (ja) * 1983-11-30 1985-06-25 Takeda Chem Ind Ltd インタ−フェロンの製造法
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
DE3421302A1 (de) * 1984-06-08 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
US4572798A (en) * 1984-12-06 1986-02-25 Cetus Corporation Method for promoting disulfide bond formation in recombinant proteins
US5248769A (en) * 1985-06-26 1993-09-28 Cetus Oncology Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4748234A (en) * 1985-06-26 1988-05-31 Cetus Corporation Process for recovering refractile bodies containing heterologous proteins from microbial hosts
US4675387A (en) 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
US5252708A (en) * 1990-11-23 1993-10-12 Roussel Uclaf Preparation process for a protein containing at least one intramolecular disulphide bridge by oxidation, at a pH of less than 5.0 of corresponding reduced recombinant protein
DE4128319A1 (de) * 1991-08-27 1993-03-04 Bioferon Biochem Substanz Neues rekombinantes human-ifn-beta, verfahren zu dessen herstellung und dieses enthaltende pharmazeutische zubereitungen
FR2686899B1 (fr) * 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
ATE268810T1 (de) * 1995-12-21 2004-06-15 Genzyme Corp Methode zur zellyse
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
AU1275899A (en) 1997-10-24 1999-05-17 Megabios Corporation Methods for preparing polynucleotide transfection complexes
JPH11335392A (ja) 1998-05-26 1999-12-07 Hsp Kenkyusho:Kk 可溶性タンパク質の回収方法
AU2001266557A1 (en) * 2000-04-12 2001-10-23 Human Genome Sciences, Inc. Albumin fusion proteins
US20050100991A1 (en) * 2001-04-12 2005-05-12 Human Genome Sciences, Inc. Albumin fusion proteins
CA2446739A1 (en) * 2001-05-25 2002-12-05 Human Genome Sciences, Inc. Chemokine beta-1 fusion proteins
UY27373A1 (es) * 2001-07-09 2003-02-28 Schering Ag Formulaciones de interferón beta-humano
KR101271635B1 (ko) * 2001-12-21 2013-06-12 휴먼 게놈 사이언시즈, 인코포레이티드 알부민 융합 단백질
EP2261250B1 (de) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin Fusionsproteine
WO2003059934A2 (en) * 2001-12-21 2003-07-24 Human Genome Sciences, Inc. Albumin fusion proteins
US7314746B2 (en) 2002-09-13 2008-01-01 Valentis, Inc. Apparatus and method for preparative scale purification of nucleic acids
CA2513213C (en) 2003-01-22 2013-07-30 Human Genome Sciences, Inc. Albumin fusion proteins
JP2007526317A (ja) * 2004-03-01 2007-09-13 エンゾン ファーマスーティカルズ インコーポレイテッド インターフェロン−ベータ・ポリマー結合体
WO2005099855A1 (en) * 2004-04-07 2005-10-27 Waters Investments Limited Compositions and methods for separating enantiomers
DE102004047189A1 (de) 2004-09-29 2006-04-06 Robert Bosch Gmbh Sensor zur Ortung metallischer Objekte sowie Verfahren zur Auswertung von Messsignalen eines solchen Sensors
US9534013B2 (en) * 2006-04-12 2017-01-03 Horizon Pharma Rheumatology Llc Purification of proteins with cationic surfactant
CA2604399A1 (en) 2005-04-11 2006-10-19 Savient Pharmaceuticals, Inc. Variant forms of urate oxidase and use thereof
EP2111230A4 (de) * 2006-12-19 2010-11-17 Merrimack Pharmaceuticals Inc Gemeinsame verabreichung von alpha-fetoprotein und einem immunmodulierungsmittel zur behandlung von multipler sklerose
EP2207890A4 (de) * 2007-10-05 2010-12-15 Barofold Inc Hochdruckbehandlung aggregierter interferone
JP5639039B2 (ja) 2008-04-11 2014-12-10 メリマック ファーマシューティカルズ インコーポレーティッド ヒト血清アルブミンリンカーおよびそのコンジュゲート
JP5773366B2 (ja) 2008-04-21 2015-09-02 ティシュー リジェネレイション セラピューティックス、インコーポレイテッド 生物学的又は化学的作用物質に対する予防又はそれらの治療のために遺伝子改変されたヒト臍帯血管周囲細胞
WO2010059315A1 (en) * 2008-11-18 2010-05-27 Merrimack Pharmaceuticals, Inc. Human serum albumin linkers and conjugates thereof
BRPI1012951A2 (pt) 2009-06-09 2016-07-26 Defyrus Inc "administração de interferon para profilaxia ou tratamento de infecção por patôgeno"
KR101861547B1 (ko) 2009-06-25 2018-07-02 크레알타 파마슈티칼스 엘엘씨 페길화된 유리카아제 치료 중에 혈청 요산을 모니터링하여 주입 반응의 위험성 및 반응의 항체­매개 상실을 예측하는 방법 및 키트
US9345766B2 (en) 2012-08-30 2016-05-24 Merrimack Pharmaceuticals, Inc. Combination therapies comprising anti-ERBB3 agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
AU538665B2 (en) * 1979-10-30 1984-08-23 Juridical Foundation, Japanese Foundation For Cancer Research Human interferon dna
GB2068970B (en) * 1980-02-06 1983-06-22 Searle & Co Recombinant dna technique for the preparation of a protein resembling human interferon
DE3005897A1 (de) * 1980-02-16 1981-09-03 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enhtaltenden mikroorganismus
US4315852A (en) * 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria

Also Published As

Publication number Publication date
JPH0449999B2 (de) 1992-08-13
CA1187013A (en) 1985-05-14
JPS59500597A (ja) 1984-04-12
AU549721B2 (en) 1986-02-06
IT8347779A0 (it) 1983-02-24
IT1164626B (it) 1987-04-15
EP0102989A1 (de) 1984-03-21
WO1983003103A1 (en) 1983-09-15
AU1331783A (en) 1983-10-18
US4450103A (en) 1984-05-22
EP0102989B1 (de) 1986-05-28

Similar Documents

Publication Publication Date Title
DE3363647D1 (en) Process for recovering human ifn-beta from a transformed microorganism
DE3662597D1 (en) Process for recovering gas byproducts from refuse
DE3064130D1 (en) Process for recovering interferon
GB2181452B (en) Leaching process
ZA794825B (en) A process for recovering solid cyanuric chloride
EP0345083A3 (en) Process for recovering methacrolein
YU2386A (en) Process for producing sheet from circonium alloy
ZA875687B (en) Process for recovering metals
PH22497A (en) Process for recovering primary normal aliphatic higher alcohols
DE3262275D1 (en) Process for operating a fluidized bed
EP0088408A3 (en) Process for preparing 2-keto-l-gulonic acid and a mutant
DE3274985D1 (en) Process for recovering a dipeptide derivative
DE3371796D1 (en) Metal recovery process
GB2203420B (en) Process for the recovery of metals
DE3365847D1 (en) Process for recovering ethyleneamines
HUT34209A (en) Process for producing cephtazidime i.e. a cephemecarboxylic acid derivative and intermediate
MY8700408A (en) A process for recovering leuicine from protein hydrolysates
YU43795B (en) Process for foam-flotation
YU98181A (en) Process for recovering metals
DE3167533D1 (en) Process for recovering interferon
MY8600095A (en) Process for recovering purified monosidium glutamate
ZA825628B (en) A process for the recovery of metals
DE3376340D1 (en) Leucine dehydrogenase and a process for production thereof
YU42282A (en) Process for recovering heavy metals
GB2163773B (en) Process for recovering tertiary butylstyrene

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: CHIRON CORP. (N.D.GES.D. STAATES DELAWARE), EMERYV